COMMUNIQUÉS West-GlobeNewswire

Tonix Pharmaceuticals Announces New Patent Coverage Protecting Tonmya®
07/11/2018
NEW YORK, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) today announced that the U.S. Patent and Trademark Office ("USPTO") issued U.S. Patent No. 10,117,936 [...]
R1 RCM Reports Third Quarter 2018 Results
07/11/2018
CHICAGO, Nov. 07, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management services to healthcare providers, today announced results for the three months [...]
Client Outlook Partners with PocketHealth to Give Patients Access to Imaging Records
07/11/2018
WATERLOO, Ontario, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Client Outlook, a leading provider of FDA Class II enterprise diagnostic and clinical image viewing solutions, announced today its partnership with PocketHealth to [...]
Pieris Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update
07/11/2018
Company to Host an Investor Conference Call on Wednesday, November 7, 2018 at 8:00 AM EST BOSTON, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) , a clinical-stage biotechnology company [...]
BeiGene Reports Third Quarter 2018 Financial Results
07/11/2018
CAMBRIDGE, Mass. and BEIJING, China, Nov. 07, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]
Emblem Corp. announces new board appointments
07/11/2018
TORONTO, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”) today announced the appointment of Connie A. Stefankiewicz and Loreto Grimaldi to its Board of Directors (the [...]
BeiGene Initiates Global Head-to-Head Phase 3 Clinical Trial of Zanubrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
07/11/2018
CAMBRIDGE, Mass. and BEIJING, China, Nov. 07, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]
Melinta Therapeutics Reports Third Quarter 2018 Financial Results
07/11/2018
New Product Launches Continue to Make Progress Setting the Stage for Growth in 2019 Entered Commercial Agreement with Menarini Group to market Vabomere®, Orbactiv® and Minocin® for Injection in 68 Countries Outside the [...]
Aleafia Announces Special Meeting of Shareholders
07/11/2018
TORONTO, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Aleafia Health Inc. ( TSXV: ALEF; OTCQX: ALEAF, FRA: ARAH ) (“ Aleafia “) or (the “ Company “) is announcing that it will hold a special meeting (the “ Meeting ”) of [...]
Emerald Health Therapeutics Fulfilling Supply Commitments with Provincial Adult-Use Cannabis Shipments
07/11/2018
Emerald delivers first shipments to British Columbia and Newfoundland and Labrador VICTORIA, British Columbia, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV:EMH; OTCQX:EMHTF) has [...]
Clementia Reports Third Quarter 2018 Operating Results and Pipeline Updates
07/11/2018
Recent FDA Meeting Identifies Path Towards NDA Submission in the Second Half of 2019 Financing Raises $75 million to Support a Potential Commercial Launch MONTREAL, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Clementia [...]
Clementia présente ses résultats d’exploitation pour le troisième trimestre de 2018, ainsi qu’une mise à jour de son portefeuille de produits
07/11/2018
Une rencontre récente avec la FDA ouvre la voie à la soumission d’une NDA au second semestre de 2019 Une activité de financement rapporte 75 M$ pour la réalisation d’un lancement commercial potentiel MONTRÉAL, 07 nov. [...]
Foamix Announces Positive Topline Results from Phase 3 Program Evaluating FMX103 Topical Minocycline Foam for Moderate-to-Severe Papulopustular Rosacea
07/11/2018
FMX103 Demonstrated Highly Statistically Significant Improvement Compared with Vehicle in Both Co-Primary Efficacy Endpoints Conference Call and Webcast Today at 8:30 a.m. ET REHOVOT, Israel and BRIDGEWATER, N.J., Nov. [...]
A Q&A Session With RavenQuest CEO George Robinson
07/11/2018
VANCOUVER, British Columbia, Nov. 07, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) We’re heading swiftly through the final quarter of 2018 and [...]
Momenta Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update
07/11/2018
CAMBRIDGE, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA) today reported its financial results for the third quarter ended September 30, 2018 and provided a corporate update. “We [...]
Achillion Reports Third Quarter 2018 Financial Results
07/11/2018
- Completed enrollment of Phase 2 clinical trial of ACH-4471 in PNH as monotherapy - - Interim data and strategic update planned for December 17, 2018 – - September 30, 2018 cash & securities position of $283 [...]
Tetraphase Pharmaceuticals to Present at Upcoming Investor Conferences
07/11/2018
WATERTOWN, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening [...]
Immunicum AB (publ) Interim Report July - September 2018
07/11/2018
Press Release 7 November 2018 Immunicum AB (publ) Interim Report July - September 2018 Positive preclinical results presented at ESMO Significant Events During the Third Quarter Immunicum announced protocol approval by [...]
Rule 2.9 Announcement
07/11/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 7 November 2018 [...]

Pages